Last reviewed · How we verify
NCT03947554
Ginseng HRG80 in Stress and Fatigue
Phase 1, PHASE2 trial testing HRG80 Panax ginseng in Psychological Stress in 50 participants. Completed in 1 July 2019.
15 June 2019
Quick facts
| Lead sponsor | EuroPharma, Inc. |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 50 |
| Start date | 1 April 2019 |
| Primary completion | 15 June 2019 |
| Estimated completion | 1 July 2019 |
| Sites | 1 location across Armenia |
Drugs / interventions tested
- HRG80 Panax ginseng
- Panax ginseng — full drug profile →
- Placebo
Conditions studied
- Psychological Stress — all drugs for Psychological Stress →
Sponsor
EuroPharma, Inc.
Who can join
Adults 18 to 65, any sex, with Psychological Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effects of a specific herbal preparation of Panax ginseng in preventing symptoms of stress in healthy individuals.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of <i>Panax ginseng</i> Meyer Herbal Preparation HRG80 in Preventing and Mitigating Stress-Induced Failure of Cognitive Functions in Healthy Subjects: A Pilot, Randomized, Double-Blind, Placebo-Controlled Crossover Trial.
Mariage PA, Hovhannisyan A, Panossian AG. · · 2020 · cited 18× · PMID 32235339 · DOI 10.3390/ph13040057
Verify or expand the search:
- PubMed search for NCT03947554
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychological Stress
Currently open trials in the same condition.
- NCT07101458 — The Eswatini PRISM Study on Adolescents Living With HIV · NA · recruiting
- NCT06899165 — Psilocybin-Assisted Therapy for Intergenerational Trauma · Phase 2 · recruiting
- NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
- NCT06788106 — Effect of Aerobic Exercise With Synchronous Music on Functions Among Medical Students · NA · recruiting
- NCT06795061 — Fitness Buddy Program to Boost Physical Activity in University Students · NA · active not recruiting
Other EuroPharma, Inc. trials
Trials by the same sponsor.
- NCT04932265 — Effect of Gamma-cyclodextrin on the Bioavailability of Ginsenosides · Phase 1 · suspended
- NCT04167449 — Effects of Korean Red Ginseng Extract on Electrical Brain Activity in Elderly Subjects · Phase 4 · completed
- NCT03780621 — Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment · Phase 1 · completed
- NCT03461380 — Effect of Menopause Relief EP-40 in Women With Menopausal Symptoms · Phase 2 · completed
- NCT03463018 — Echinacea Angustifolia (AnxioCalm) in Anxiety · Phase 2 · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03947554 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by EuroPharma, Inc.
- Last refreshed: 5 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03947554.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing